Rachel Moseley is principal academic in psychology at Bournemouth University in the United Kingdom. Her research centers around issues that autistic adults face, including mental ill-health, suicidality, self-injury, aging and late diagnosis. She also investigates aspects of cognition and social communication in autistic people and how these differ depending on personal characteristics, such as sex.
Rachel Moseley
Principal academic
Bournemouth University
From this contributor
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
Menopause poses significant challenges for autistic people, according to a small survey published in 2020 — the first to explore the transition among people with autism traits.
Autism and menopause: Q&A with Rachel Moseley and Julie Turner-Cobb
By
Shelby Grebbin
7 April 2022 | 5 min read
Autism and eating disorders may have an emotional connection
Eating disorders have the highest mortality rates of any kinds of mental illness. They don’t discriminate, affecting people of all ethnicities, sexualities, gender identities, ages and backgrounds.
Autism and eating disorders may have an emotional connection
By
Rachel Moseley, Laura Renshaw-Vuillier, The Conversation
12 August 2020 | 5 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read